50 EUR
3
6.38%
Last update Dec 12, 12:51 PM CET
Market closed
Day range
48
50
Previous close
47
Open
49
Access this stock data via API
Subscribe
Crispr Therapeutics AG
50.00
3
6.38%

Statistics

Valuation metrics
Market cap
4.77B
Enterprise value
2.61B
Trailing P/E (ttm)
-11.52
Forward P/E
PEG ratio
-0.73
Price/Sales (ttm)
124.29
Price/Book (mrq)
2.88
Enterprise Value/Revenue
79.83
Enterprise Value/EBITDA
-6.66
Overview
Shares outstanding
93.87M
Float
94.80M
Shares short
% Held by insiders
1.61%
% Held by institutions
77.94%
Average volume (10 days)
517
Average volume (90 days)
352
Price summary
52-Week low
29.20
52-Week high
68.50
52-Week change
20 68.5%
Beta
1.73
50-Day moving average
52.21
200-Day moving average
46.43
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
-215%
Operating margin
-14,854.78%
Operational effectiveness
Return on assets
-13.28%
Return on equity
-25.33%
Income statement
Revenue (ttm)
32.65M
Revenue per share (ttm)
0.44
Quarterly revenue growth (yoy)
47.70%
Gross profit (ttm)
-366.82M
EBITDA
-391.37M
Net income to common (ttm)
-415.91M
Diluted EPS (ttm)
-4.72
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
1.63B
Total cash per share (mrq)
20.10
Total debt (mrq)
179.74M
Total Debt/Equity (mrq)
11.01
Current ratio (mrq)
1,621.70%
Book value per share (mrq)
17.38
Cash flow
Cash flow statement
-257.65M
Levered free cash flow (LFCF)
-176.16M
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 5 hours 36 minutes

02:23
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).